Back
Bicycle Therapeutics PLC Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
3
BCYC
Bicycle Therapeutics PLC
Last Price:
$6.70
Seasonality Move:
-8.39%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Bicycle Therapeutics PLC Stock Forecast
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 11.3% based on the past 5 years of stock performance.
-
Bicycle Therapeutics PLC has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Bicycle Therapeutics PLC Stock Undervalued?The current Bicycle Therapeutics PLC [BCYC] share price is $6.53. The Score for BCYC is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
-
BCYC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Bicycle Therapeutics PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 11.3% based on the past 5 years of stock performance.
Bicycle Therapeutics PLC Stock Rating
Sell
3
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC overpriced?
-
Bicycle Therapeutics PLC has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Bicycle Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bicycletherapeutics.com
52-Week Data
52-Week High:
28.67
52-Week Low:
6.10
Prediction Charts
Market Cap:
451.9M
Price in USD:
6.53
Volume:
250.3K
Beta:
0.94
Technical Analysis
SMA50:
10.37
SMA100:
13.74
SMA200:
18.53
52-Wk Change:
-71.6%
Stock Predictions
-
Is Bicycle Therapeutics PLC stock public?Yes, Bicycle Therapeutics PLC is a publicly traded company.
-
What is the Bicycle Therapeutics PLC stock quote today?The Bicycle Therapeutics PLC stock price is 6.53 USD today.
-
How to buy Bicycle Therapeutics PLC stock online?You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 9.23 | 9.20 | 9.35 | 8.88 |
| Mar-25 | 9.25 | 8.85 | 9.44 | 8.75 |
| Mar-26 | 8.85 | 8.73 | 9.10 | 8.60 |
| Mar-27 | 9.25 | 9.19 | 9.69 | 9.00 |
| Mar-28 | 9.10 | 8.97 | 9.55 | 8.89 |
| Mar-31 | 8.72 | 8.49 | 8.90 | 8.20 |
| Apr-1 | 8.42 | 7.85 | 8.42 | 7.85 |
| Apr-2 | 7.80 | 8.05 | 8.25 | 7.80 |
| Apr-3 | 7.73 | 7.43 | 7.90 | 7.41 |
| Apr-4 | 7.17 | 6.89 | 7.41 | 6.77 |
| Apr-7 | 6.60 | 6.75 | 7.09 | 6.27 |
| Apr-8 | 7.11 | 6.38 | 7.28 | 6.31 |
| Apr-9 | 6.76 | 6.88 | 6.98 | 6.10 |
| Apr-10 | 6.69 | 6.53 | 6.82 | 6.38 |
Bicycle Therapeutics PLC Earnings
Bicycle Therapeutics PLC Earnings Report: Per Share Bicycle Therapeutics PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bicycle Therapeutics PLC Forecast Revenue Growth
Bicycle Therapeutics PLC Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.27 per share, and a decrease next year of $0.56 per share.
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.